Rifaximin
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Treatment of traveler’s diarrhea due to noninvasive E. coli
- Reduction in risk of overt hepatic encephalopathy recurrence
- Treatment of Irritable Bowel Syndrome-diarrhea predominant (IBS-D)
NON-FDA APPROVED USES
- C. difficile-associated diarrhea (prevention, or second-line treatment)
- Small bowel bacterial overgrowth
- Prevention of traveler’s diarrhea
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Treatment of traveler’s diarrhea due to noninvasive E. coli
- Reduction in risk of overt hepatic encephalopathy recurrence
- Treatment of Irritable Bowel Syndrome-diarrhea predominant (IBS-D)
NON-FDA APPROVED USES
- C. difficile-associated diarrhea (prevention, or second-line treatment)
- Small bowel bacterial overgrowth
- Prevention of traveler’s diarrhea
There's more to see -- the rest of this entry is available only to subscribers.